Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Let's stay focused..

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Jun 21, 2024 4:12pm

186 Views

Post# 36100714

RE:RE:RE:RE:RE:Let's stay focused..

I don't think there is going to be a buyout very easily. This is RDW's legacy. Game change to oncology care (which I believe it can be). He wants to ride it to the top one day.

FDA approval is for sure in my mind. You don't get have many oncology drugs that can care the malignancy in a third of patients after 1 (maybe 2) treatments.

However, it could still be slow as TLT doesn't have the money for the top tier FDA consultants.

<< Previous

Bullboard Posts

Next >>

This junior mining stock offers billions in market exposure